Prognostic value of suPAR and hs-CRP on cardiovascular disease

Piepoli, 2016, Atherosclerosis, 252, 207, 10.1016/j.atherosclerosis.2016.05.037 Yeboah, 2015, Utility of nontraditional risk markers in individuals ineligible for statin therapy according to the 2013 american College of cardiology/american heart association cholesterol guidelines, Circulation, 132, 916, 10.1161/CIRCULATIONAHA.115.016846 Naghavi, 2003, From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies, Part II. Circulation, 108, 1772, 10.1161/01.CIR.0000087481.55887.C9 Cavanaugh-Hussey, 2008, Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool, Prev. Med., 47, 619, 10.1016/j.ypmed.2008.07.012 Lyngbæk, 2013, Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score, Int. J. Cardiol., 167, 2904, 10.1016/j.ijcard.2012.07.018 Erbel, 2010, Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis, J. Am. Coll. Cardiol., 56, 1397, 10.1016/j.jacc.2010.06.030 Polonsky, 2010, Coronary artery calcium score and risk classification for coronary heart disease prediction, Jama, 303, 1610, 10.1001/jama.2010.461 Goff, 2014, 2013 ACC/AHA guideline on the assessment of cardiovascular risk, J. Am. Coll. Cardiol., 63, 2935, 10.1016/j.jacc.2013.11.005 Libby, 2009, Leducq transatlantic Network on atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice, J. Am. Coll. Cardiol., 54, 2129, 10.1016/j.jacc.2009.09.009 Collaboration ERF, 2010, C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis, Lancet, 375, 132, 10.1016/S0140-6736(09)61717-7 Eugen-Olsen, 2010, Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population: suPAR: a novel risk marker for major disease and mortality, J. Intern. Med., 268, 296, 10.1111/j.1365-2796.2010.02252.x Thunø, 2009, suPAR: the molecular crystal ball, Dis. Markers, 27, 157, 10.1155/2009/504294 Diederichsen, 2012, Discrepancy between coronary artery calcium score and HeartScore in middle-aged Danes: the DanRisk study, Eur. J. Prev. Cardiol., 19, 558, 10.1177/1741826711409172 Lambrechtsen, 2012, The relation between coronary artery calcification in asymptomatic subjects and both traditional risk factors and living in the city centre: a DanRisk substudy, J. Intern. Med., 271, 444, 10.1111/j.1365-2796.2011.02486.x Sørensen, 2014, Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects, Atherosclerosis, 237, 60, 10.1016/j.atherosclerosis.2014.08.035 Budoff, 2009, Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic study of atherosclerosis), J. Am. Coll. Cardiol., 53, 345, 10.1016/j.jacc.2008.07.072 Pencina, 2011, Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers, Stat. Med., 30, 11, 10.1002/sim.4085 Yeboah, 2012, Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals, Jama, 308, 788, 10.1001/jama.2012.9624 Persson, 2014, Soluble urokinase plasminogen activator receptor: a risk factor for carotid plaque, stroke, and coronary artery disease, Stroke, 45, 18, 10.1161/STROKEAHA.113.003305 McClelland, 2015, 10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors, J. Am. Coll. Cardiol., 66, 1643, 10.1016/j.jacc.2015.08.035 Qureshi, 2015, Risk stratification for primary prevention of coronary artery disease: roles of C-Reactive protein and coronary artery calcium, Curr Cardiol Rep [Internet], 17 Arad, 2005, Disease events, J. Am. Coll. Cardiol., 46, 158, 10.1016/j.jacc.2005.02.088 Park, 2002, Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals, Circulation, 106, 2073, 10.1161/01.CIR.0000033819.29662.09 Möhlenkamp, 2011, Quantification of coronary atherosclerosis and inflammation to predict coronary events and all-cause mortality, J. Am. Coll. Cardiol., 57, 1455, 10.1016/j.jacc.2010.10.043 Eapen, 2014, Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events, J. Am. Heart Assoc., 3 Jenny, 2010, Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis, Atherosclerosis, 209, 226, 10.1016/j.atherosclerosis.2009.08.037 Diederichsen, 2017, CT-detected growth of coronary artery calcification in asymptomatic middle-aged subjects and association with 15 biomarkers, JACC Cardiovasc. Imaging, 10, 858, 10.1016/j.jcmg.2017.05.010 Yousuf, 2013, High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?, J. Am. Coll. Cardiol., 62, 397, 10.1016/j.jacc.2013.05.016 Legány, 2015, Increased plasma soluble urokinase plasminogen activator receptor levels in systemic sclerosis: possible association with microvascular abnormalities and extent of fibrosis, Clin Chem Lab Med CCLM [Internet], 53 Asciutto, 2013, Treatment with beta-blockers is associated with lower levels of Lp-PLA2 and suPAR in carotid plaques, Cardiovasc. Pathol., 22, 438, 10.1016/j.carpath.2013.04.005 Bjerrum, 2013, Non-invasive assessments reveal that more than half of randomly selected middle-aged individuals have evidence of subclinical atherosclerosis: a DanRisk substudy, Int J Cardiovasc Imaging, 29, 301, 10.1007/s10554-012-0091-8